Jincaopian not checked
Beijing Konruns Pharmaceutical Co., Ltd. · ZY5301
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
2 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Chronic Pelvic Pain (2 trials)
- Main trialPhase 3
- “The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease”In the company’s words, NCT05970783 on ClinicalTrials.gov
- Other names
- ZY5301
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Unknown | 11 Mar 2024 | A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease | |
| Phase 2Completed | 30 Nov 2021 | The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026